Cargando…

Model‐informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID‐19

AIM: We hypothesized that viral kinetic modelling could be helpful to prioritize rational drug combinations for COVID‐19. The aim of this research was to use a viral cell cycle model of SARS‐CoV‐2 to explore the potential impact drugs, or combinations of drugs, that act at different stages in the vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dodds, Michael G., Krishna, Rajesh, Goncalves, Antonio, Rayner, Craig R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451752/ https://www.ncbi.nlm.nih.gov/pubmed/32693436 http://dx.doi.org/10.1111/bcp.14486

Ejemplares similares

Systematic integration of biomedical knowledge prioritizes drugs for repurposing
por: Himmelstein, Daniel Scott, et al.
Publicado: (2017)

Systematically Prioritizing Candidates in Genome-Based Drug Repurposing
por: Challa, Anup P., et al.
Publicado: (2019)

Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing
por: Garana, Belinda B., et al.
Publicado: (2023)

Drepmel—A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment
por: Thompson, Zachary J., et al.
Publicado: (2022)

A Maximum Flow-Based Approach to Prioritize Drugs for Drug Repurposing of Chronic Diseases
por: Islam, Md. Mohaiminul, et al.
Publicado: (2021)

Task-driven knowledge graph filtering improves prioritizing drugs for repurposing
por: Ratajczak, Florin, et al.
Publicado: (2022)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

Drug Repurposing Approaches to Combating Viral Infections
por: Trivedi, Jay, et al.
Publicado: (2020)

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
por: Kern, Charlotte, et al.
Publicado: (2021)

A novel network based linear model for prioritization of synergistic drug combinations
por: Li, Jiaqi, et al.
Publicado: (2022)

Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential
por: Lo, Yu-Chen, et al.
Publicado: (2017)

Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization
por: Kulkarni, Ameya S., et al.
Publicado: (2022)

Metabolic modeling-based drug repurposing in Glioblastoma
por: Tomi-Andrino, Claudio, et al.
Publicado: (2022)

A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization
por: Schultz, Bruce, et al.
Publicado: (2021)

Drug repurposing screens and synergistic drug‐combinations for infectious diseases
por: Zheng, Wei, et al.
Publicado: (2017)

Synergistic drug combinations and machine learning for drug repurposing in chordoma
por: Anderson, Edward, et al.
Publicado: (2020)

HPO-Shuffle: an associated gene prioritization strategy and its application in drug repurposing for the treatment of canine epilepsy
por: Wang, Shuguang, et al.
Publicado: (2019)

A network-biology led computational drug repurposing strategy to prioritize therapeutic options for COVID-19
por: Khurana, Pankaj, et al.
Publicado: (2022)

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19
por: Rayner, Craig R., et al.
Publicado: (2020)

Drug Repurposing for Viral Infectious Diseases: How Far Are We?
por: Mercorelli, Beatrice, et al.
Publicado: (2018)

Insights into bioinformatic approaches for repurposing compounds as anti-viral drugs
por: Zheng, Wenxiao, et al.
Publicado: (2021)

Drug repurposing for aging research using model organisms
por: Ziehm, Matthias, et al.
Publicado: (2017)

Exploiting large-scale drug-protein interaction information for computational drug repurposing
por: Liu, Ruifeng, et al.
Publicado: (2014)

Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing
por: Udrescu, Lucreţia, et al.
Publicado: (2016)

Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets
por: Dobbs Spendlove, Mauri, et al.
Publicado: (2023)

Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
por: Gelemanović, Andrea, et al.
Publicado: (2021)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion
por: Wilk, Elizabeth J., et al.
Publicado: (2023)

Drug target prioritization by perturbed gene expression and network information
por: Isik, Zerrin, et al.
Publicado: (2015)

A drug repurposing screen for whipworms informed by comparative genomics
por: Coghlan, Avril, et al.
Publicado: (2023)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

Modeling Path Importance for Effective Alzheimer’s Disease Drug Repurposing
por: Xiang, Shunian, et al.
Publicado: (2023)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Pre-Clinical Drug Prioritization via Prognosis-Guided Genetic Interaction Networks
por: Xiong, Jianghui, et al.
Publicado: (2010)

A deep learning ensemble approach to prioritize antiviral drugs against novel coronavirus SARS-CoV-2 for COVID-19 drug repurposing
por: K., Deepthi, et al.
Publicado: (2021)

Deep graph embedding for prioritizing synergistic anticancer drug combinations
por: Jiang, Peiran, et al.
Publicado: (2020)

Repurposing Drugs in Small Animal Oncology
por: Giuliano, Antonio, et al.
Publicado: (2022)

Biased random walk model for the prioritization of drug resistance associated proteins
por: Guo, Hao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_94ip1u09kjfe7896fbkci7i3kv